Lonza Group AG

Industry

  • Services
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Drug Discovery Technologies
  • Digital Health
    • Disease Management
  • Diversified
  • Contract Research Organization-CRO

Other Names/Subsidiaries

  • Algonomics NV
  • Capsugel S.A.
  • HansaBioMed Life Sciences OÜ
  • InterHealth Nutraceuticals
  • Lonza Group
  • MODA Technology
  • Micro-Macinazione S.A.
  • PharmaCell B.V.
  • Synaffix B.V.
  • Triangle Research Labs
  • Zelam
  • Zelam Holdings.
See more in Biomedtracker

Latest on Lonza Group AG

Scrip

Deal Watch: Lilly Looks To Alchemab’s ‘Resilient’ Antibodies To Take On ALS

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A

Scrip

Deal Watch: Merck Decides Better Late Than Never In GLP-1 Deal With Hansoh

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck Obtains Global Rights To Hansoh’

Scrip

Financing Is Improving, But Cell And Gene Therapy Firms May Be Last To Feel It

 
• By Mandy Jackson

The overall flow of funding into the biopharmaceutical industry is increasing in 2024 relative to 2022 and 2023, but investors continue to see risk in the drug development sector, placing their bets o

In Vivo

For Nascent Exosome Field, One Company’s Win Is Everyone’s Gain

 
• By David Wild

From potential use as gene therapy delivery vehicles to anti-inflammatory therapies and cancer drugs, there has been excitement around exosomes since these stem cell components were first observed in